InnoVEX Pitch Contest Winners

Share

Rapid Diagnostic Systems - NAOR

Israel

Healthcare & Biotech

Startup Terrace Award (ST Award)
 
 
 
Looking for

NaorCov19- Saliva based Molecular Diagnostic for COVID-19

Rapid Saliva based Molecular Diagnostic for non-lab settings, initially for COVID-19. Carries CE mark as a Molecular Diagnostic. Revolutionary mechanism to allow for 40 minutes results without expensive infrastructure or skill set. Color change based results with a unique saliva buffer that allows for a robust, scalable workflow and results.

Company Description

A Rapid, saliva based point-of-care, simplified molecular diagnostic platform using RT-LAMP. The platform is applicable to any virus or bacteria with an RNA. We had received the CE mark for its COVID-19 saliva rapid test. Perform anywhere, by anyone; Simple and rapid process: Collect, Heat (10 min. at 95c and then 30 min. at 65c), Look for color change; Easy and self- collected saliva samples and simple processing; Unlimited testing capacity of samples side-by-side, using standard heaters. Originated from the Israeli Technion with a multidisciplinary team trained at Harvard, Weizmann and Columbia Universities. Developed in collaboration with the Israeli Ministry of Defense R&D Arm.

Company News

[{"bannerId":"629b8ec4-1696-4dd6-bb12-9bb3d284819f","imgPathWide":"/2022/_uploads/202205191916183762.jpg","imgPathThin":null,"go2Url":"https://innovex.computex.biz/show/videolist.aspx","ifOpenNew":false,"landAt":"2022default","seq":1},{"bannerId":"353a44f2-3080-4bb6-b52b-0a6864ab27cb","imgPathWide":"/2022/_uploads/202205221307161472.jpg","imgPathThin":null,"go2Url":"https://innovex.computex.biz/show/videolist.aspx","ifOpenNew":false,"landAt":"2022default","seq":3}]